CRIO to Collaborate with ArisGlobal
Cambridge, MA - Clinical Research IO (CRIO), a Cambridge-based technology company that has developed the first eSource system built and marketed directly to clinical research sites, announced today that it will collaborate with ArisGlobal to streamline clinical research.
CRIO’s system replaces the paper forms used at many research sites with an interactive web and tablet-based application. Using the system, researchers are able to configure eSource templates, and capture data quickly and accurately. By digitizing the collection of source data by investigators and integrating with other solutions, the company offers sponsors improved data quality and streamlined workflows.
Under the collaboration effort between CRIO and ArisGlobal, data captured electronically in CRIO will integrate with ArisGlobal’s agCapture, an electronic data capture system, and its integrated CTMS solution, thus eliminating double data entry and source data verification, two activities that consume up to 20% of the total time spent on a clinical trial.
“This collaboration is an excellent example of the cross-vendor collaboration required to resolve challenges in clinical research,” said Phuc Truong, co-founder of CRIO. “With this integration, we can give principal investigators and their staff an extremely user-friendly interface to collect data in way that’s consistent with their workflows, and ArisGlobal can deliver their life science sponsors immediate access to accurate data that does not need source verification.”
“Integration with Clinical Research IO further ours mission of offering life sciences companies a full lifecycle solution to enhance data quality and streamline operations,” said David Laky, Vice President of ArisGlobal – Clinical Solutions. “Many of our clients are looking for a solution to take out cost and time while enhancing data quality, and through this collaboration, we can deliver exactly that solution.”
Clinical Research IO (CRIO)
CRIO is the leading eSource solution for clinical research sites. Since its launch in September, 2016, it has signed up 50 research sites, and is now deployed on over 60 studies. For more information, visit www.clinicalresearch.io.
ArisGlobal
ArisGlobal’s cloud-based solutions facilitate global drug development and regulatory compliance within the life sciences and healthcare industries. Its cloud platform supports the entire product life cycle including clinical development, regulatory affairs, safety and pharmacovigilance and medical communications. Visit arisglobal.com, or follow ArisGlobal on LinkedIn and Twitter.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
